Ikanekt Biomedical Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 22-12-2024
- Paid Up Capital ₹ 0.16 M
as on 22-12-2024
- Company Age 1 Year 10 Months
- Last Filing with ROC 31 Mar 2024
About Ikanekt Biomedical Technologies
The Company is engaged in the Software Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.16 M, as per Ministry of Corporate Affairs (MCA) records.
Srirang Ramamoorthy, Vajramuni Balaramaiah, and Diddigi Bhardwaj serve as directors at the Company.
- CIN/LLPIN
U72200TZ2023PTC027817
- Company No.
027817
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Feb 2023
- Date of AGM
22 Oct 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ikanekt Biomedical Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vajramuni Balaramaiah  | Director | 26-Jul-2023 | Current |
| Srirang Ramamoorthy | Director | 22-Feb-2023 | Current |
| Diddigi Bhardwaj | Director | 22-Feb-2023 | Current |
Financial Performance of Ikanekt Biomedical Technologies.
Enhance accessibility to Ikanekt Biomedical Technologies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Ikanekt Biomedical Technologies?
Unlock access to Ikanekt Biomedical Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Ikanekt Research And Development Private LimitedActive 6 years 2 months
Srirang Ramamoorthy is a mutual person
- Gemn Research & Development Private LimitedActive 10 years 6 months
Vajramuni Balaramaiah is a mutual person
- Gemn Technical Solutions And Services Private LimitedActive 9 years 6 months
Vajramuni Balaramaiah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ikanekt Biomedical Technologies?
Unlock and access historical data on people associated with Ikanekt Biomedical Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ikanekt Biomedical Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ikanekt Biomedical Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
